Michelle Li
Medical · Dumont, NJNPI 1932506094
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 217 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by AbbVie at 30.8% of the total. Reporting peaked in 2023 at $2,036 and has fallen 60.1% since, to $812 in 2025. Among medical clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 217 payments — averaging $30.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Gilead$1K
- GSK$544
- IBSA Pharma Inc.$432
- Amgen$385
- Sanofi$293
- plus $2K from 13 others
What the payments were for
- Food & beverage$6,658100%
- Education$70%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 78 | $2,052 |
| Gilead | 43 | $1,315 |
| GSK | 24 | $544 |
| IBSA Pharma Inc. | 5 | $432 |
| Amgen | 9 | $385 |
| Sanofi | 2 | $293 |
| Boehringer Ingelheim | 8 | $259 |
| Novo Nordisk | 10 | $259 |
| Lilly USA, LLC | 11 | $224 |
| AstraZeneca | 3 | $159 |
| Esperion Therapeutics, Inc. | 1 | $150 |
| Madrigal Pharmaceuticals | 1 | $150 |
| Biohaven Pharmaceutical Holding Company Ltd. | 6 | $127 |
| Merck | 5 | $104 |
| Amarin Pharma, Inc. | 4 | $76 |
| Nestle Healthcare Nutrition Inc. | 4 | $75 |
| Radius Health, Inc. | 1 | $20 |
| Amneal Pharmaceuticals LLC | 1 | $20 |
| Redhill Biopharma Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,665 in reported general payments places this provider in the 90th percentile of 573 medical providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VascepaIcosapent Ethyl | 322 | $149,255 |
| JardianceEmpagliflozin | 50 | $43,071 |
| JanuviaSitagliptin Phosphate | 41 | $32,081 |
| VemlidyTenofovir Alafenamide | 21 | $31,815 |
| RybelsusSemaglutide | 26 | $29,841 |
| OzempicSemaglutide | 20 | $26,928 |
| JanumetSitagliptin Phos/Metformin Hcl | 21 | $17,491 |
| RestasisCyclosporine | 22 | $16,390 |
| EliquisApixaban | 16 | $16,186 |
| LinzessLinaclotide | 20 | $14,787 |
| SynjardyEmpagliflozin/Metformin Hcl | 21 | $14,732 |
| JentaduetoLinagliptin/Metformin Hcl | 19 | $13,929 |
| Diclofenac Epolamine | 41 | $12,828 |
| Jentadueto XrLinagliptin/Metformin Hcl | 16 | $7,995 |
| Icosapent Ethyl | 38 | $7,639 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Synjardy, Jentadueto, Jentadueto Xr | $259 | $79,727106 claims |
| Novo NordiskRybelsus, Ozempic | $259 | $56,76946 claims |
| MerckJanuvia, Janumet | $104 | $49,57262 claims |
| AbbVieRestasis, Linzess, Synthroid | $2,052 | $31,93454 claims |
| GileadVemlidy | $1,315 | $31,81521 claims |
| GSKShingrix | $544 | $2,63615 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 573 medical providers in New Jersey.
Other medical in Dumont
- Shannon WelnerVerona$176K
- Christinna DelgenioColts Neck$114K
- Anita FoxVerona$17K
- Therese CasasKinnelon$16K
- Joseph CollettiLinwood$16K
- Melissa MiaoKearny$14K
- Gabriela Plesek-AndiaVerona$13K
- Stephanie PhillipsMarlton$12K
- Sean AdairCape May Court House$12K
- Shane CourtneyLinwood$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.